Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
Go back to Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 239.62 -5.56 (2.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $245.18 | 52 Week High | $196.47 | |||
| Open | $249.13 | 52 Week Low | $127.10 | |||
| Day High | $250.06 | P/E | 266.24 | |||
| Day Low | $236.42 | EPS | $0.90 | |||
| Volume | 32,588,031 | |||||
| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 320.71 -2.02 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $322.73 | 52 Week High | $141.32 | |||
| Open | $322.00 | 52 Week Low | $97.79 | |||
| Day High | $322.70 | P/E | 51.31 | |||
| Day Low | $319.38 | EPS | $6.25 | |||
| Volume | 1,738,508 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.89 -0.25 (6.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.14 | 52 Week High | $45.34 | |||
| Open | $4.15 | 52 Week Low | $15.92 | |||
| Day High | $4.17 | P/E | 1.67 | |||
| Day Low | $3.86 | EPS | $2.33 | |||
| Volume | 3,509,958 | |||||
